• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishDashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form 6-K filed by LexinFintech Holdings Ltd.

    5/22/25 6:03:50 AM ET
    $LX
    Finance: Consumer Services
    Finance
    Get the next $LX alert in real time by email
    6-K 1 lx-2025_q1_6k.htm 6-K 6-K

     

     

    UNITED STATES

    SECURITIES AND EXCHANGE COMMISSION

    WASHINGTON, D.C. 20549

     

    FORM 6-K

     

    REPORT OF FOREIGN PRIVATE ISSUER

    PURSUANT TO RULE 13a-16 OR 15d-16 UNDER

    THE SECURITIES EXCHANGE ACT OF 1934

     

    For the month of May 2025

    Commission File Number: 001-38328

     

    LexinFintech Holdings Ltd.

     

    27/F CES Tower

    No. 3099 Keyuan South Road

    Nanshan District, Shenzhen 518057

    The People's Republic of China

    (Address of principal executive offices)

     

    Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.

    Form 20-F ___X____ Form 40-F _________

     

     


     

    SIGNATURES

    Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

     

    LexinFintech Holdings Ltd.

     

     

     

     

    By

     

    /s/ James Xigui Zheng

    Name:

     

    James Xigui Zheng

    Title:

     

    Chief Financial Officer

     

    Date: May 21, 2025

     

     

     


     

    Exhibit Index

    Exhibit 99.1—Press Release

     

     


    Get the next $LX alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $LX

    DatePrice TargetRatingAnalyst
    11/26/2024Neutral → Buy
    Citigroup
    11/24/2023Buy → Neutral
    Citigroup
    3/16/2023$3.45Outperform → Buy
    CLSA
    3/14/2023$2.31 → $3.60Neutral → Buy
    Citigroup
    2/1/2023Neutral → Buy
    UBS
    5/31/2022Buy → Neutral
    Citigroup
    12/20/2021$4.30Buy → Neutral
    UBS
    More analyst ratings